RyboDyn
Healthcare & Life Sciences
Recent Finacing
Seed
Recent Raise
$4M
RyboDyn, Inc. is a biotechnology company developing cancer immunotherapies using proprietary RNA sequencing technology to target the cryptic human proteome.
Focus Areas
Biotechnology
Cancer Immunotherapy
RNA Sequencing
Proteome Discovery
Drug Development
Dark Genome
Investors
